Bio-Rad Laboratories, Inc. (BIO) stock analysis

BIO · Bio-Rad Laboratories, Inc.

Latest recorded price: USD 360.58

Model-estimated fair value: USD 104.44. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Medical Devices

At $360.58, BIO trades 245.3% above the model's base-case value of $104.44. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $86.12 in the conservative case and $123.65 in the optimistic case, with a valuation confidence score of 91/100. Fiscal 2025 figures: revenue growth -2.7%, free cash flow margin 14.5%, ROIC 0.5%. The model does not flag any risk signals for this company.

Similar companies in Healthcare